试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-04
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD
编号:NCT02515669登记状态:提前终止企业 / 申办者:Hoffmann-La Roche
药物 / 成分:RO7239361、Placebo
登记的停止原因(原文):A pre-planned futility analysis indicated lack of efficacy in study NCT03039686 and led to discontinuation of both ongoing studies in DMD.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-04
Improving Labour Induction Analgesia: Epidural Fentanyl Bolus at Epidural Initiation for Induction of Labour
编号:NCT04011098登记状态:提前终止企业 / 申办者:University of Saskatchewan
药物 / 成分:Epidural Fentanyl Bolus、Standard Epidural Group
登记的停止原因(原文):Unable to meet recruitment numbers, lack of participation
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-03
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)
编号:NCT00485589登记状态:提前终止企业 / 申办者:Genentech, Inc.
药物 / 成分:Methotrexate、Ocrelizumab、Placebo
登记的停止原因(原文):Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-03
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
编号:NCT00503581登记状态:提前终止企业 / 申办者:Gynecologic Oncology Group
药物 / 成分:Biopsy、Laboratory Biomarker Analysis、Megestrol Acetate、Pharmacological Study
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-03
Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery
编号:NCT00661466登记状态:提前终止企业 / 申办者:Innocoll
药物 / 成分:Bupivacaine Collagen Sponge、Placebo
登记的停止原因(原文):Business decision
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-03
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
编号:NCT01656252登记状态:提前终止企业 / 申办者:PrECOG, LLC.
药物 / 成分:Phase I- Cytarabine & Eltrombopag、Phase II- Sequence A、Phase II- Sequence B
登记的停止原因(原文):Study stopped per Novartis request due to futility from another study.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-03
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
编号:NCT02010567登记状态:提前终止企业 / 申办者:UNC Lineberger Comprehensive Cancer Center
药物 / 成分:CRLX101、Capecitabine、Radiotherapy、Surgery
登记的停止原因(原文):The study was halted prematurely at the funding partner's request.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-03
Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
编号:NCT03184584登记状态:提前终止企业 / 申办者:Liminal BioSciences Ltd.
药物 / 成分:PBI-4050
登记的停止原因(原文):Terminated early due to redeployment of study site staff during Covid-19 pandemic
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-02
Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
编号:NCT00107081登记状态:提前终止企业 / 申办者:Swiss Pediatric Oncology Group
药物 / 成分:ciprofloxacin and amoxicillin、Outpatient management、i.v. antibiotics、inpatient management
登记的停止原因(原文):Accrual goal for interventional part not achievable
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-11-02
Comparison Trial of Enema vs. PEG 3350 for Constipation
编号:NCT00467350登记状态:提前终止企业 / 申办者:Children's Mercy Hospital Kansas City
药物 / 成分:PEG 3350、milk and molasses enema
登记的停止原因(原文):concern patients in oral cleaout arm had worse outcome
查看官方原始记录 ↗